Mathieu Bosset
159, Boulevard Maréchal Juin
Valence, 26000, France
Valence, 26000, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Radiotherapy for laryngeal cancers: 2025 update.
Journal: Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
Published: March 12, 2025
Robustness evaluation of an artificial intelligence-based automatic contouring software in daily routine practice.
Journal: Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)
Published: December 23, 2024
Survival Without Quality of Life Deterioration in the GORTEC 2014-04 "OMET" Randomized Phase 2 Trial in Patients with Head and Neck Cancer with Oligometastases using Stereotactic Ablative Radiation Therapy (SABR) alone or Chemotherapy and SABR.
Journal: International journal of radiation oncology, biology, physics
Published: July 15, 2024
Afatinib maintenance therapy following post-operative radiochemotherapy in head and neck squamous cell carcinoma: Results from the phase III randomised double-blind placebo-controlled study BIB2992ORL (GORTEC 2010-02).
Journal: European journal of cancer (Oxford, England : 1990)
Published: August 04, 2022
Radiation induced brachial plexopathy: Diagnosis, risk factors, principles of care
Journal: Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
Published: February 10, 2022
Low dose radiotherapy for COVID-19 pneumopathy: Biological rationale and literature review
Journal: Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
Published: February 19, 2021
A priori quality assurance using a benchmark case of the randomized phase 2 GORTEC 2014-14 in oligometastatic head and neck cancer patients.
Journal: Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
Published: February 16, 2021
Salvage radiotherapy with or without short-term hormone therapy for rising prostate-specific antigen concentration after radical prostatectomy (GETUG-AFU 16): a randomised, multicentre, open-label phase 3 trial.
Journal: The Lancet. Oncology
Published: December 09, 2015
Interobserver variability study for daily cone beam computed tomography registration of prostate volumetric modulated arc therapy
Journal: Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
Published: January 30, 2015
Showing 1-9 of 9
Last Updated: 09/26/2026